Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Current Leases (2016 - 2025)

iBio (IBIO) has disclosed Current Leases for 10 consecutive years, with $518000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 152.68% to $518000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $518000.0, a 152.68% increase, with the full-year FY2025 number at $53000.0, down 87.84% from a year prior.
  • Current Leases was $518000.0 for Q4 2025 at iBio, up from $504000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $518000.0 in Q4 2025 to a low of $10000.0 in Q1 2022.
  • A 5-year average of $284450.0 and a median of $301000.0 in 2022 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: tumbled 96.86% in 2022, then surged 2550.0% in 2023.
  • iBio's Current Leases stood at $45000.0 in 2021, then surged by 600.0% to $315000.0 in 2022, then fell by 9.52% to $285000.0 in 2023, then dropped by 28.07% to $205000.0 in 2024, then surged by 152.68% to $518000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Current Leases are $518000.0 (Q4 2025), $504000.0 (Q3 2025), and $53000.0 (Q2 2025).